GITNUX MARKETDATA REPORT 2024

Statistics About The Most Chronic Bloodborne Disease In Us

The most chronic bloodborne disease in the US, hepatitis C, affects approximately 2.4 million individuals.

In the following blog post, we will examine key statistics related to hepatitis C, the most chronic bloodborne disease in the United States. From the increasing incidence rates and the importance of early intervention to the impact on vulnerable populations and the potential for life-saving treatments, these statistics shed light on the urgent need for awareness, prevention, and access to care in the fight against hepatitis C.

Statistic 1

"Awareness campaigns are critical for increasing hepatitis C screening rates."

Sources Icon

Statistic 2

"Incidence of acute hepatitis C has increased fourfold from 2009 to 2018."

Sources Icon

Statistic 3

"Early antiviral therapy is crucial to prevent liver disease progression."

Sources Icon

Statistic 4

"Hepatitis C is a leading cause of liver transplants in the United States."

Sources Icon

Statistic 5

"Hepatitis C disproportionately affects marginalized and vulnerable populations."

Sources Icon

Statistic 6

"New infections are largely driven by the opioid crisis and associated needle sharing."

Sources Icon

Statistic 7

"Approximately 15,000 Americans die each year from hepatitis C-related liver diseases."

Sources Icon

Statistic 8

"Direct-acting antiviral medications can cure more than 95% of people with hepatitis C."

Sources Icon

Statistic 9

"Over 1 million people globally die each year from hepatitis C complications."

Sources Icon

Statistic 10

"The U.S. Preventive Services Task Force recommends screening for hepatitis C in all adults aged 18 to 79."

Sources Icon

Statistic 11

"About 2.4 million people in the U.S. are living with hepatitis C."

Sources Icon

Statistic 12

"Hepatitis C causes more deaths in the United States than any other infectious disease reported to the CDC."

Sources Icon

Statistic 13

"Approximately 75%–85% of people who become infected with hepatitis C virus develop chronic infection."

Sources Icon

Statistic 14

"50%–75% of people with chronic hepatitis C are unaware they are infected."

Sources Icon

Statistic 15

"Hepatitis C is the most common bloodborne infection in the United States."

Sources Icon

Statistic 16

"Universal hepatitis C screening could save thousands of lives annually."

Sources Icon

Statistic 17

"Chronic hepatitis C may lead to liver cirrhosis or liver cancer."

Sources Icon

Statistic 18

"Baby boomers (born 1945-1965) are five times more likely to have hepatitis C."

Sources Icon

Statistic 19

"Injection drug use is the primary risk factor for new hepatitis C infections."

Sources Icon

Statistic 20

"The cost of hepatitis C treatment can exceed $84,000 for a 12-week course."

Sources Icon
In conclusion, the statistics highlight the urgent need for increased awareness, proactive screening efforts, and access to early antiviral therapy for hepatitis C in the United States. The significant rise in acute cases, the high mortality rate, and the disproportionate impact on marginalized populations underscore the importance of public health initiatives and targeted interventions. With effective treatments available and recommended screening guidelines in place, implementing universal screening measures and addressing key risk factors such as injection drug use can potentially save thousands of lives annually and reduce the burden of liver-related complications associated with chronic hepatitis C infection.

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!